PURA-Related Neurodevelopmental Disorders with Epilepsy Treated with Ketogenic Diet: A Case-Based Review

Raffaele Falsaperla1,2,3, Vincenzo Sortino2, Marina Antonietta Schinocca4

  • 1Neonatal Intensive Care Unit and Neonatal Accompaniment Unit, Azienda Ospedaliero-Universitaria Policlinico "Rodolico-San Marco", San Marco Hospital, University of Catania, 95123 Catania, Italy.

Genes
|July 27, 2024
PubMed

Insights

PURA syndrome, a genetic disorder, can present with new symptoms like sialorrhea and seizures. A ketogenic diet (KD) showed effectiveness in managing these symptoms in a young patient.

Area of Science:

  • Genetics
  • Neurodevelopmental disorders
  • Metabolic therapies

Background:

  • PURA syndrome is a rare congenital disorder resulting from de novo mutations in the PURA gene.
  • The PURA gene encodes a crucial DNA/RNA-binding protein involved in gene regulation.
  • Classical PURA deficiency presents with developmental delays and neurological issues.

Observation:

  • An 11-year-old patient with a de novo frameshift variant in the PURA gene was identified via whole exome sequencing (WES).
  • This patient exhibited classical PURA deficiency features alongside severe sialorrhea (drooling) and epilepsy (seizures).
  • The patient's sialorrhea and seizures showed significant improvement following the implementation of a ketogenic diet (KD).

Findings:

  • This case documents the first instance of successful management of sialorrhea and seizures in PURA syndrome using a ketogenic diet.
  • A novel frameshift deletion in the PURA gene was identified, expanding the known spectrum of genetic variants associated with the syndrome.
  • While a direct mechanistic link was not established, the clinical response to KD suggests a potential metabolic or neurological pathway influenced by the PURA mutation.

Implications:

  • The findings suggest that ketogenic diet therapy may be a viable therapeutic option for managing specific symptoms in PURA syndrome.
  • This case highlights the importance of considering metabolic interventions for neurological manifestations in rare genetic disorders.
  • Further research is warranted to elucidate the potential mechanisms underlying the efficacy of KD in this context and its broader applicability.

Related Concept Videos

Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
182
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
150
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
317
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
305
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
363